Clinical Trial Update: Efficacy and Safety Study of Enzalutamide in Combination With Exemestane in Patients With Advanced Breast Cancer [Phase 2]

View source ↗

Summary

Pfizer reported Phase 2 trial results evaluating the combination of enzalutamide and exemestane in advanced breast cancer, focusing on efficacy and safety outco…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Enzalutamide (enzalutamide)
• Exemestane (Exemestane)

Snippet

Sponsor: Pfizer | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2018-02-06